Results 91 to 100 of about 6,382 (203)

Investigation of the antimycobacterial activity of African medicinal plants combined with chemometric analysis to identify potential leads

Scientific Reports
The emergence of drug-resistant Mycobacterium tuberculosis strains is a threat to global health necessitating the discovery of novel chemotherapeutic agents.
Phanankosi Moyo, Michael Ofori, Olusola S. Bodede, Madelien Wooding, Ndivhuwo Kevin Khorommbi, Lyndy J. McGaw, Cynthia A. Danquah, Vinesh J. Maharaj   +7 more
doaj   +1 more source

L’inibizione delle metalloproteasi: applicazioni terapeutiche nelle patologie reumatiche [PDF]

, 1999
Purpose: Matrix metalloproteinases (MMPs) play an important role in the degradation of articular cartilage in several diseases, including osteorthritis and rheumatoid arthritis.
PANTALEONI GC, DI GIULIO, Antonio, MINISOLA G, AMICOSANTE, Gianfranco, FRANCESCHINI, Nicola, ORATORE A, BARRACCHINI A   +6 more
core  

In vitro Characterization of Wild-type and Rifamycin-resistant Mycobacterium tuberculosis RNA polymerases. [PDF]

, 2012
Rifampin (a semi-synthetic rifamycin derivative) is one of the first-line anti-tuberculosis drugs. Rifampin inhibits transcription by binding to the beta-subunit of the RNA polymerase (RNAP).
Atwal, Sumandeep Kaur
core  

Isolation, identification, and pathogenic potential of Bacillus cereus from diseased big‐belly seahorse Hippocampus abdominalis

Journal of the World Aquaculture Society
Members of Bacillus cereus have been documented as important bacterial pathogens in aquaculture. However, scarce information is available on B. cereus isolates as causal pathogens of big‐belly seahorses Hippocampus abdominalis. In the present study, a B.
Chunlei Gai, Chenhao Teng, Yueqi Yang, Yiyao Liu, Haijing Jie, Youhong Wang, Haibin Ye, Haipeng Cao   +7 more
doaj   +1 more source

Beyond Rifampin: Evaluating Rifapentine and Rifabutin as Alternative Treatments for TB Meningitis. [PDF]

J Infect Dis
Chen X, Ruiz-Gonzalez CE, Masias-Leon Y, Singh M, Nino-Meza OJ, Peloquin CA, Artemov D, Jain SK.   +7 more
europepmc   +1 more source

Tuberculosis Prevention in Pregnant Women Living with HIV: A Review of the Current Management Strategies and Guidance. [PDF]

Infect Drug Resist
Darveau SC, Yadav S, Dooley KE, Mathad JS.   +3 more
europepmc   +1 more source

New rifamycins [PDF]

, 1988
W.A. Vischer, P. Traxler, O. Zak
core   +1 more source

Salinirifamycins A-E: Rifamycin S Derivatives from the Brazilian Marine Actinomycete Salinispora arenicola. [PDF]

J Nat Prod
Batista da Silva A, Pinto FCL, Silveira ER, Paulo TF, Wilke DV, Ferreira EG, Costa-Lotufo LV, Canuto KM, Marinho-Filho JDB, Barros AB, Nuzzo G, Fontana A, Monteiro NKV, Pessoa ODL.   +13 more
europepmc   +1 more source

Correction: Evaluating the efficacy of HRZE-based regimens in a high-burden murine model: a back-translational assessment of rifamycins and moxifloxacin substitutions in tuberculosis treatment. [PDF]

Front Pharmacol
Cummings JE, Woolhiser LK, Guglielmi V, Wernsman M, Romano A, Pauly S, Belisle JT, Walter ND, Robertson GT, Slayden RA.   +9 more
europepmc   +1 more source

Therapeutic drug monitoring-guided treatment of XDR TB with an RpoB I491F mutation-a case report. [PDF]

JAC Antimicrob Resist
Klingmüller A, Zuber S, Hoffmann AM, Köhler N, Suárez I, Preßel T, Niemann S, Dreyer V, Decosterd LA, Choong E, Schütz B, Friesen I, Rybniker J.   +12 more
europepmc   +1 more source